Market Place
Sourcing Support
Xencor To Host R&D Webcast And Conference Call On September 9, 2024
06 Sep 2024 //
BUSINESSWIRE
Medivir presents data on additive activity of fostrox with Lenvima or sorafenib
07 Sep 2023 //
PR NEWSWIRE
Accord`s Sorafenib Receives Approval in Europe
25 Nov 2022 //
EMA
Yabao`s Generic Sorafenib Tosylate Receives Approval in the U.S.
09 Nov 2022 //
FDA
Camrelizumab with Rivoceranib vs. Sorafenib, a Joint Program with Elevar
11 Sep 2022 //
PRNEWSWIRE
Dr. Reddy`s launches generic version of Nexavar Tablets
14 Jun 2022 //
BIOSPACE
Dr Reddys Labs` Generic Sorafenib Tosylate Receives Approval in the U.S
07 Jun 2022 //
FDA
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet
26 Apr 2022 //
ENDPTS
Exelixis` Final OS Results from Phase 3 COSMIC-31 Trial of Cabozantinib in Combo
14 Mar 2022 //
BUSINESSWIRE
Innovative phase 2 trial targets advanced liver cancer
25 Jan 2022 //
PHARMATIMES
Dosing Begins in Randomised Phase 2 Clinical Trial of MTL-CEBPA
25 Jan 2022 //
BUSINESSWIRE
IMFINZI + Tremelimumab Demonstrated Unprecedented Survival in Liver Cancer
18 Jan 2022 //
BUSINESSWIRE
Exelixis: Phase 3 Results Trial of Cabozantinib + Immune Checkpoint Inhibitor
20 Nov 2021 //
BUSINESSWIRE
Keytruda’s liver success again raises the Asia question
28 Sep 2021 //
EVALUATE
Merck grabs lifeline for problematic Keytruda liver cancer nod
28 Sep 2021 //
FIERCEPHARMA
Merck`s KEYTRUDA Met Primary Endpoint of OS inAdvanced Hepatocellular Carcinoma
27 Sep 2021 //
BUSINESSWIRE
Teva Pharms USA`s Generic Icosapent Ethyl Receives Approval In US
17 Nov 2020 //
FDA
Mylan Pharms`s Generic Sorafenib Receives Approval In US
10 Sep 2020 //
FDA
Novocure Enrolls Last Patient in HEPANOVA Trial Testing Tumor Fields Sorafenib
07 Jul 2020 //
BUSINESSWIRE
MiNA Therapeutics Presents Top Line Results from Phase Ib Study of MTL?CEBPA
28 May 2020 //
BUSINESSWIRE
MiNA Announces Initiation of Phase I Clinical Study of MTL?CEBPA in Combination
03 Mar 2020 //
BUSINESSWIRE
MiNA Therapeutics Announces Initiation of Phase I Clinical Study of MTL?CEBPA
03 Mar 2020 //
BUSINESSWIRE
OnQuality Pharma raises $15m for drug to treat VEGF side effects
30 Oct 2019 //
PHARMAPHORUM
Bristol-Myers Squibb`s Opdivo couldn`t topple Nexavar in HCC
27 Sep 2019 //
ENDPTS
With Stronger OS Data, AVEO Plans to Seek Approval of RCC Drug Tivozanib
11 Sep 2019 //
BIOSPACE
Meet the protein responsible for nearly $100B in cancer drug deals
17 Aug 2019 //
BIOPHARMADIVE
Transgene terminates oncolytic IO combo trial in advanced liver cancer
08 Aug 2019 //
PHARMAFILE
SillaJen to discontinue PHOCUS trial for advanced liver cancer
05 Aug 2019 //
BIOSPECTRUMASIA
Phase 3 trial of Transgene`s oncolytic virus halted for futility
03 Aug 2019 //
FIERCE BIOTECH
YABAO PHARM`s generic SORAFENIB TOSYLATE Receives Tentative Approval in US
10 Jul 2019 //
FDA
Bristol-Myers Squibb’s Opdivo misses its shot at earlier use in liver cancer
25 Jun 2019 //
FIERCE PHARMA
Bayer hunts for rare glioblastoma nod with `Big 5` contender
21 Jun 2019 //
FIERCE PHARMA
Autolus’ next-gen CAR-T looks promising in ALL
03 Apr 2019 //
MEDPAGETODAY
MiNA Presents Pre-Clinical Data Supporting Combination MTL-CEBPA with Sorafenib
02 Apr 2019 //
BUSINESSWIRE
Israeli biotech flunks PhII liver cancer study, but it insists drug
26 Mar 2019 //
ENDPTS
Stivarga final NICE recommendation for hepatocellular carcinoma
09 Jan 2019 //
PHARMA TIMES
NICE recommends Lenvima as alternative 1st-line therapy for Adv liver cancer
19 Dec 2018 //
PHARMAFILE
Exelixis, Ipsen Initiate Ph 3Trial of Cabozantinib+Atezolizumab vs Sorafenib
05 Dec 2018 //
BUSINESSWIRE
MSD’s Keytruda approved for liver cancer
12 Nov 2018 //
PHARMA TIMES
MSD’s Keytruda approved for liver cancer
12 Nov 2018 //
PHARMA TIMES
Lenvima backed for NHS use to treat liver cancer
09 Nov 2018 //
PHARMA TIMES
Lenvima backed for NHS use to treat liver cancer
09 Nov 2018 //
PHARMA TIMES
Nexavar (sorafenib tosylate) : Bayer HealthCare vs. Apotex Inc.
19 Oct 2018 //
PATENT LITIGATION
Novartis farms out rare disease drug to LifeMax Labs
28 Aug 2018 //
FIERCE BIOTECH
Lenvima wins green light in liver cancer
17 Aug 2018 //
PHARMA TIMES
Scientists Develop Novel Drug That Could Potentially Treat Liver Ca Better
02 Aug 2018 //
RDMAG
Exelixis Announces CELESTIAL Phase 3 Pivotal Trial Results Published in NEJM
04 Jul 2018 //
BUSINESSWIRE
Drugs with MOA Utilized by Namodenoson Recommended to Combat Liver Cancer
02 Jul 2018 //
BUSINESSWIRE
Three thyroid cancer drugs approved for NHS in England
23 Feb 2018 //
CANCERRESEARCH
NICE shoots down Bayer`s Stivarga in liver cancer
08 Nov 2017 //
FIERCE PHARMA
NICE rejects Bayer and Eisai drugs in thyroid cancer
21 Oct 2017 //
PHARMA PHORUM
Bristol’s Opdivo nivolumab Receives FDA Approval-Treated with Sorafenib
25 Sep 2017 //
PRESS RELEASE
Onxeo shares blitzed after PhIII liver cancer study flops
12 Sep 2017 //
ENDPTS
EUSA bags EU approval for kidney cancer drug
30 Aug 2017 //
PHARMA TIMES
3 in 4 Cancer Drugs Fund treatments now available on NHS
11 Aug 2017 //
CANCERRESEARCH
NICE approves Bayer`s Nexavar for primary liver cancer
11 Aug 2017 //
PHARMA TIMES
Bayer`s Nexavar backed by NICE for liver cancer
09 Aug 2017 //
PMLIVE
Teva confirms API plant will be among 15 sites shut in cost cutting plan
08 Aug 2017 //
IN PHARMATECHNOLOGIST
EMA clears Bayer`s Stivarga for liver cancer
08 Aug 2017 //
PMLIVE
